RxDefine

Veeva Ostro | Conversational AI for Life Sciences Brands

United States · $45.0M raised

Business Model
B2B
Total Funding
$45.0M
Last Round
$45.0M Venture RoundNov 2022
Rounds
1

About

RxDefine was a digital health engagement platform purpose-built for life sciences companies seeking to deliver personalized healthcare journeys to patients. The platform enabled pharmaceutical and biotech clients to design and deploy tailored patient support programs, combining data-driven personalization with adherence tools to improve health outcomes. The company rebranded to Ostro in 2022, continuing its mission under the new name with an expanded product focus on patient engagement across the full therapy lifecycle.

Summary

RxDefine is a Healthcare company based in United States. It has raised $45.0M in total across 1 round, most recently a $45.0M Venture Round round in Nov 2022.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding RoundNov 2022
$45.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RxDefine on Indexed.vc
<a href="https://indexed.vc/companies/rxdefine"><img src="https://indexed.vc/api/badge/company/rxdefine" alt="RxDefine on Indexed.vc" width="260" height="76" /></a>